Clinical presentation, prognostic factors and treatment outcome of multiple myeloma (MM) in African American (AA) patients.

被引：0
|
作者：
Badros, Ashraf Z. [1 ]
Goloubeva, Olga [1 ]
Chumsri, Saranya [1 ]
Ruehle, Kathleen [1 ]
Ning, Yi [1 ]
Meekins, Joann [1 ]
Guedez, Liliana [1 ]
Rapoport, Aaron P. [1 ]
Meisenberg, Barry [1 ]
Akpek, Gorgon [1 ]
Yanovich, Saul [1 ]
Sausville, Edward [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5024
引用
收藏
页码：345B / 345B
页数：1
相关论文
共 50 条
  • [41] African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients.
    Akhlaghi, Theresia
    Maclachlan, Kylee
    Korde, Neha
    Mailankody, Sham
    Lesokhin, Alexander M.
    Hassoun, Hani
    Lu, Sydney X.
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Derkach, Andriy
    Lahoud, Oscar Boutros
    Landau, Heather Jolie
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David J.
    Giralt, Sergio
    Usmani, Saad Zafar
    Landgren, Carl Ola
    Hultcrantz, Malin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Immunophenotype and prognosis in multiple myeloma (MM):: An analysis including 642 patients.
    Gonzalez-Fraile, MI
    Garcia-Sanz, R
    Mateo, G
    Almeida, J
    Vazquez, L
    Moro, MJ
    Fernandez-Calvo, J
    Hernandez, JM
    Del Cañizo, MC
    Blade, J
    Orfao, A
    Gonzalez, M
    San Miguel, JF
    BLOOD, 2001, 98 (11) : 157A - 158A
  • [43] Impact of t(11;14) on outcomes in African American (AA) and non-AA (NAA) patients (Pts) with newly diagnosed multiple myeloma (NDMM): Connect MM registry.
    Gasparetto, Cristina
    Abonour, Rafat
    Jagannath, Sundar
    Durie, Brian G.
    Shah, Jatin J.
    Narang, Mohit
    Terebelo, Howard R.
    Toomey, Kathleen
    Hardin, James
    Wagner, Lynne I.
    Srinivasan, Shankar
    Kitali, Amani
    Flick, E. Dawn
    Zafar, Faiza
    Agarwal, Amit
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Time to first treatment is an independent prognostic factor for multiple myeloma (MM).
    Goyal, Gaurav
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Durani, Urshila
    Paludo, Jonas
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM)
    Hatic, Haris
    Inselman, Shealeigh
    Inselman, Jonathan
    Kommalapati, Anuhya
    Tella, Sri Harsha
    Paludo, Jonas
    Durani, Urshila
    Go, Ronald S.
    Goyal, Gaurav
    LEUKEMIA RESEARCH, 2022, 123
  • [46] Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma
    Richardson, PGG
    Barlogie, B
    Berenson, J
    Singhal, S
    Jagannath, S
    Irwin, D
    Rajkumar, SV
    Hideshima, T
    Xiao, H
    Esseltine, D
    Schenkein, D
    Anderson, KC
    BLOOD, 2005, 106 (09) : 2977 - 2981
  • [47] MULTIPLE-MYELOMA - PROGNOSTIC FACTORS AND TREATMENT MODALITIES
    MICHIELS, JJ
    NETHERLANDS JOURNAL OF MEDICINE, 1992, 40 (5-6): : 254 - 270
  • [48] Clinical Features, Outcome and Prognostic Factors For Survival and Evolution To Multiple Myeloma Of Solitary Plasmacytomas: A Report Of The Greek Myeloma Study Group In 97 Patients
    Katodritou, Eirini
    Terpos, Evangelos
    Symeonidis, Argiris S.
    Pouli, Anastasia
    Kelaidi, Charikleia
    Kyrtsonis, Marie-Christine
    Kotsopoulou, Maria
    Delimpasi, Sosana
    Christoforidou, Anna
    Giannakoulas, Nikolaos
    Viniou, Nora-Athina
    Stefanoudaki, Ekaterini
    Hadjiaggelidou, Christina
    Christoulas, Dimitrios
    Verrou, Evgenia
    Gastari, Vassiliki
    Papadaki, Sofia
    Patakiouta, Freideriki
    Kastritis, Efstathios
    Kouraklis, Alexandra
    Konstantinidou, Pavlina
    Anagnostopoulos, Achilles
    Zervas, Konstantinos
    Dimopoulos, Meletios A.
    BLOOD, 2013, 122 (21)
  • [49] Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients
    Katodritou, Eirini
    Terpos, Evangelos
    Symeonidis, Argiris S.
    Pouli, Anastasia
    Kelaidi, Charikleia
    Kyrtsonis, Marie-Christine
    Kotsopoulou, Maria
    Delimpasi, Sosana
    Christoforidou, Anna
    Giannakoulas, Nikolaos
    Viniou, Nora-Athina
    Stefanoudaki, Ekaterini
    Hadjiaggelidou, Christina
    Christoulas, Dimitrios
    Verrou, Evgenia
    Gastari, Vassiliki
    Papadaki, Sofia
    Polychronidou, Genovefa
    Papadopoulou, Athina
    Giannopoulou, Evlambia
    Kastritis, Efstathios
    Kouraklis, Alexandra
    Konstantinidou, Pavlina
    Anagnostopoulos, Achilles
    Zervas, Konstantinos
    Dimopoulos, Meletios A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) : 803 - 808
  • [50] Prognostic factors and outcome of older patients with symptomatic multiple myeloma: A study of the Greek Myeloma Study Group (GMSG).
    Anagnostopoulos, A
    Gika, D
    Symeonidis, A
    Zervas, K
    Pouli, A
    Repoussis, P
    Grigoraki, V
    Anagnostopoulos, N
    Maniatis, AG
    Dimopoulos, MA
    BLOOD, 2004, 104 (11) : 294B - 294B
12345